Patient and physician-reported outcomes with tirbanibulin 1% ointment for actinic keratosis in routine clinical practice in Spain and Italy (TIRBASKIN study)
Saved in:
| Main Authors: | Y. Gilaberte, O. Yelamos, J. Cañueto, C. Serra-Guillén, A. Conti, F. Pajuelo, A. Lecchi, V. Cappello, B. Kostov, M. Romanelli |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-01-01
|
| Series: | EJC Skin Cancer |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772611824000211 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of tirbanibulin 1% ointment for the treatment of actinic keratosis in routine clinical practice in Spain and Italy (TIRBASKIN study)
by: Y. Gilaberte, et al.
Published: (2024-01-01) -
The Skin-Lightening Power of Tirbanibulin 1% Ointment
by: Federica Li Pomi, et al.
Published: (2024-11-01) -
Successful Treatment of Actinic Keratosis with Kanuka Honey
by: Saras Mane, et al.
Published: (2018-01-01) -
Actinic Keratosis Clinical Practice Guidelines: An Appraisal of Quality
by: Joslyn S. Kirby, et al.
Published: (2015-01-01) -
Real-world experience with tirbanibulin 1% ointment for the treatment of nonmelanoma skin cancer following cryotherapy: A pilot study
by: Angela Moore, MD, et al.
Published: (2025-02-01)